• Homepage
  • Webinar - Simplifying Cell Line Development with Integrated, High-throughput Tools

Wednesday, May 25, 2022

11:00 a.m. EDT | 5:00 p.m. CET | 3:00 p.m. GMT

This webinar will provide an overview of the early cell line development workflow, focusing on the iQue®3, Octet® and Ambr® 15 CC systems and how these high-throughput screening platforms can be integrated to create a more streamlined workflow. We will show how use of innovative products, coupled with expert knowledge can provide an efficient and scalable solution to cell line development, reducing the time, cost, and risk associated with early cell line development.

Register Now

What Will You Learn:

  1. The early cell line development workflow and the bottlenecks associated with the various stages
  2. How Sartorius instruments meet high-throughput demands and fit into the cell line development workflow
  3. Establishing a strategy for a simplified approach to cell line development

Meet Our Experts:

Clare Szybut, PhD

Senior Scientist, Sartorius

Clare Szybut is a senior scientist at Sartorius and currently leads the iQue® Applications group working within the European based Bio Analytics research team.  She is responsible for the research and development of novel applications for the iQue®3 advanced flow cytometry platform which aim to expand its capabilities.

An accomplished cellular biologist, Clare has 10 years’ experience in the Biotech industry where she has specialized in the development of plate-based cellular assays to support both quantitative live cell analysis and high-throughput flow cytometry.

Fern Slingsby, PhD

Product Specialist, Sartorius

Fern Slingsby has been working for Sartorius since 2018. She obtained her undergraduate degree in Molecular Biology from Queen Mary, University of London, and her PhD from the Medical Research Council (UK) / University of Edinburgh.

Fern has over 18 years of experience in recombinant protein production and upstream development.  Her background includes eight years as a project leader and program manager of biopharmaceutical cGMP manufacture from pre-clinical to clinical phase I, II and III.   

At Sartorius, Fern supports customers through incorporating high-throughput technologies into cell line and process development, focusing on the Ambr® technology and integrated platforms.

Please Complete the Form

Complete Form to Register